Oral Antiplatelet Therapy for Secondary Prevention of Acute Coronary Syndrome

Patients surviving an acute coronary syndrome (ACS) remain at increased risk of ischemic events long term. This paper reviews current evidence and guidelines for oral antiplatelet therapy for secondary prevention following ACS, with respect to decreased risk of ischemic events versus bleeding risk a...

Descripción completa

Detalles Bibliográficos
Autor principal: Berger, Jeffrey S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267535/
https://www.ncbi.nlm.nih.gov/pubmed/29987548
http://dx.doi.org/10.1007/s40256-018-0291-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267535/
https://www.ncbi.nlm.nih.gov/pubmed/29987548
http://dx.doi.org/10.1007/s40256-018-0291-2

Ejemplares similares